PT  - JOURNAL ARTICLE
AU  - Tanabe, Yasuhiro
AU  - Takahara, Mitsuyoshi
AU  - Kohsaka, Shun
AU  - Shinke, Toshiro
AU  - Takamisawa, Itaru
AU  - Amano, Tetsuya
AU  - Kanazawa, Hideaki
AU  - Suzuki, Tomomi
AU  - Kuwata, Shingo
AU  - Ishibashi, Yuki
AU  - Akashi, Yoshihiro J
AU  - Ikari, Yuji
TI  - Intracardiac echocardiography guidance for percutaneous transcatheter closure of atrial septal defects: A nationwide registry data analysis
AID  - 10.1101/2022.07.22.22277921
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.07.22.22277921
4099  - http://medrxiv.org/content/early/2022/12/12/2022.07.22.22277921.short
4100  - http://medrxiv.org/content/early/2022/12/12/2022.07.22.22277921.full
AB  - The authors have withdrawn their manuscript because they decided to modify their analysis because of how the imaging devices are employed in the real-world practice in Japan. Instead of simply comparing ICE vs. TEE patients, they decided that 3-way comparison comparing patients that underwent ASD closure with ICE alone vs. TEE alone vs Both Modalities is more practical and send clinically useful messages to the practicing physicians. Since it is highly likely that the above analysis will alter subsequent conclusions, the authors decided to withdraw the present version of their manuscript. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Japanese Association of Cardiovascular?Intervention and Therapeutics (CVIT Japan), the Grants in-Aid for Scientifc Research from the Japan Society for the Promotion of Science (KAKENHI No. 16KK0186, 16H05215 and 17K09493).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol and analyses of the J-SHD registry were approved by the Institutional Review Board of the St. Marianna University School of Medicine (Kawasaki-city, Kanagawa, Japan, Ethics Committee Approval No. 4312).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes